Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹112, the stock trades at a trailing P/E ratio of 11x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 26% over the past three years. Reported Earnings • May 28
Full year 2026 earnings released: EPS: ₹10.19 (vs ₹5.29 in FY 2025) Full year 2026 results: EPS: ₹10.19 (up from ₹5.29 in FY 2025). Revenue: ₹4.37b (up 17% from FY 2025). Net income: ₹733.4m (up 93% from FY 2025). Profit margin: 17% (up from 10% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 14% per year. Anuncio • May 18
Ganesh Benzoplast Limited to Report Q4, 2026 Results on May 27, 2026 Ganesh Benzoplast Limited announced that they will report Q4, 2026 results on May 27, 2026 Board Change • May 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. Non-Executive Independent Woman Director Amruta Thali was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹92.23, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years. Reported Earnings • Feb 16
Third quarter 2026 earnings released: EPS: ₹2.24 (vs ₹2.55 in 3Q 2025) Third quarter 2026 results: EPS: ₹2.24 (down from ₹2.55 in 3Q 2025). Revenue: ₹1.13b (up 27% from 3Q 2025). Net income: ₹161.5m (down 12% from 3Q 2025). Profit margin: 14% (down from 21% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹80.46, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 46% over the past three years. Buy Or Sell Opportunity • Jan 27
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 18% to ₹70.48. The fair value is estimated to be ₹90.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 8.2%. Reported Earnings • Nov 19
Second quarter 2026 earnings released: EPS: ₹3.30 (vs ₹2.29 in 2Q 2025) Second quarter 2026 results: EPS: ₹3.30 (up from ₹2.29 in 2Q 2025). Revenue: ₹990.0m (up 1.4% from 2Q 2025). Net income: ₹237.6m (up 44% from 2Q 2025). Profit margin: 24% (up from 17% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings. Anuncio • Sep 26
Ganesh Benzoplast Limited Appoints Amruta Pankaj Thali as Independent Woman Director Ganesh Benzoplast Limited in its Annual General Meeting held on September 25, 2025 approved to appoint Ms. Amruta Pankaj Thali (DIN:11230644) as an Independent Woman Director of the Company. Reported Earnings • Aug 12
First quarter 2026 earnings released: EPS: ₹2.52 (vs ₹2.28 in 1Q 2025) First quarter 2026 results: EPS: ₹2.52 (up from ₹2.28 in 1Q 2025). Revenue: ₹1.01b (up 15% from 1Q 2025). Net income: ₹181.3m (up 10% from 1Q 2025). Profit margin: 18% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 10% per year, which means it is performing significantly worse than earnings. Anuncio • Aug 11
Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2025 Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2025, at 11:00 Indian Standard Time. Anuncio • Aug 04
Ganesh Benzoplast Limited to Report Q1, 2026 Results on Aug 11, 2025 Ganesh Benzoplast Limited announced that they will report Q1, 2026 results on Aug 11, 2025 Valuation Update With 7 Day Price Move • May 22
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹107, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 11% over the past three years. Reported Earnings • May 15
Full year 2025 earnings released: EPS: ₹5.29 (vs ₹9.07 in FY 2024) Full year 2025 results: EPS: ₹5.29 (down from ₹9.07 in FY 2024). Revenue: ₹3.92b (down 18% from FY 2024). Net income: ₹380.9m (down 38% from FY 2024). Profit margin: 9.7% (down from 13% in FY 2024). Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 4% per year. Anuncio • May 10
Ganesh Benzoplast Limited to Report Q4, 2025 Results on May 14, 2025 Ganesh Benzoplast Limited announced that they will report Q4, 2025 results at 9:15 AM, Indian Standard Time on May 14, 2025 New Risk • Apr 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Apr 02
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹126, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 17% over the past three years. Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹127, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 29% over the past three years. Reported Earnings • Feb 13
Third quarter 2025 earnings released: EPS: ₹2.55 (vs ₹2.34 in 3Q 2024) Third quarter 2025 results: EPS: ₹2.55 (up from ₹2.34 in 3Q 2024). Revenue: ₹934.1m (down 12% from 3Q 2024). Net income: ₹183.9m (up 14% from 3Q 2024). Profit margin: 20% (up from 15% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Anuncio • Feb 07
Ganesh Benzoplast Limited to Report Q3, 2025 Results on Feb 12, 2025 Ganesh Benzoplast Limited announced that they will report Q3, 2025 results on Feb 12, 2025 New Risk • Jan 28
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.52b (US$98.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹145, the stock trades at a trailing P/E ratio of 16.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 52% over the past three years. Reported Earnings • Nov 15
Second quarter 2025 earnings released: EPS: ₹2.29 (vs ₹2.33 in 2Q 2024) Second quarter 2025 results: EPS: ₹2.29. Revenue: ₹1.02b (flat on 2Q 2024). Net income: ₹164.6m (up 5.6% from 2Q 2024). Profit margin: 16% (in line with 2Q 2024). Anuncio • Nov 09
Ganesh Benzoplast Limited to Report Q2, 2025 Results on Nov 14, 2024 Ganesh Benzoplast Limited announced that they will report Q2, 2025 results on Nov 14, 2024 Anuncio • Aug 13
Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2024 Ganesh Benzoplast Limited, Annual General Meeting, Sep 25, 2024, at 11:00 Indian Standard Time. Reported Earnings • Aug 13
First quarter 2025 earnings released: EPS: ₹2.28 (vs ₹2.37 in 1Q 2024) First quarter 2025 results: EPS: ₹2.28. Revenue: ₹912.4m (down 25% from 1Q 2024). Net income: ₹164.3m (up 6.1% from 1Q 2024). Profit margin: 18% (up from 13% in 1Q 2024). The increase in margin was driven by lower expenses. Anuncio • Aug 03
Ganesh Benzoplast Limited to Report Q1, 2025 Results on Aug 12, 2024 Ganesh Benzoplast Limited announced that they will report Q1, 2025 results on Aug 12, 2024 Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹160, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 4.5% over the past year. Reported Earnings • Jun 04
Full year 2024 earnings released: EPS: ₹9.07 (vs ₹8.73 in FY 2023) Full year 2024 results: EPS: ₹9.07 (up from ₹8.73 in FY 2023). Revenue: ₹4.91b (up 17% from FY 2023). Net income: ₹614.4m (up 12% from FY 2023). Profit margin: 13% (in line with FY 2023). Anuncio • May 23
Ganesh Benzoplast Limited to Report Q4, 2024 Results on May 30, 2024 Ganesh Benzoplast Limited announced that they will report Q4, 2024 results on May 30, 2024 Anuncio • May 08
Ganesh Benzoplast Limited Announces Resignation of Raunak Pilani as Non-Executive (Non-Independent) Director Ganesh Benzoplast Limited informed that Mr. Raunak Pilani has tendered his resignation as a non-executive (non-independent) director of the Company with effect from May 6, 2024 and the Board has accepted his resignation vide circulatory resolution passed on May 07, 2024. Anuncio • Mar 01
Ganesh Benzoplast Limited announced that it has received INR 324 million in funding On March 1, 2024, Ganesh Benzoplast Limited, closed the transaction. Reported Earnings • Feb 13
Third quarter 2024 earnings released: EPS: ₹2.34 (vs ₹2.33 in 3Q 2023) Third quarter 2024 results: EPS: ₹2.34 (up from ₹2.33 in 3Q 2023). Revenue: ₹1.08b (up 8.9% from 3Q 2023). Net income: ₹160.8m (up 11% from 3Q 2023). Profit margin: 15% (in line with 3Q 2023). Anuncio • Feb 02
Ganesh Benzoplast Limited to Report Q3, 2024 Results on Feb 12, 2024 Ganesh Benzoplast Limited announced that they will report Q3, 2024 results on Feb 12, 2024 Valuation Update With 7 Day Price Move • Jan 30
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to ₹199, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 41% over the past year. Anuncio • Jan 29
Ganesh Benzoplast Limited announced that it expects to receive INR 324 million in funding Ganesh Benzoplast Limited announced a private placement of 2,000,000 common shares at a price of INR 162 per share for gross proceeds of INR 324,000,000 on January 29, 2024. The transaction will include participation from new individual investor Anil Kumar Goel. The company will issue shares on preferential basis. The transaction has been approved by the board of directors of the company. The transaction still needs to be approved at the extra ordinary general meeting of the company to be held on February 21, 2024. Anuncio • Jan 12
Ganesh Benzoplast Limited announced that it has received INR 303.5 million in funding from Malabar Investments, LLC, Susram Financial Services & Realty Private Limited On January 12, 2024, Ganesh Benzoplast Limited closed the transaction. Anuncio • Dec 05
Ganesh Benzoplast Limited announced that it expects to receive INR 303.5 million in funding from Malabar Investments, LLC, Susram Financial Services & Realty Private Limited Ganesh Benzoplast Limited announced a private placement of up to 17,00,000 equity shares at a price of INR 160 per share (including premium of INR 159 per share) of face value INR 1 per share for gross proceeds of INR 272,000,000 and 1,80,000 equity shares at a price of INR 175 per share(including premium of INR 159 per share) for gross proceeds of INR 31,500,000 for aggregate proceeds of INR 303,500,000 on December 5, 2023. The transaction include participation from new investors, Malabar India Fund Limited and Susram Financial Services and Realty Private Limited. The issuance is made on Preferential Issue in accordance with Chapter V of the SEBI ICDR Regulations and other applicable law and the Securities & Exchange Board of India. Malabar India Fund Limited will subscribe for 17,00,000 shares and Susram Financial Services and Realty Private Limited will subscribe for 1,80,000 shares. Reported Earnings • Nov 08
Second quarter 2024 earnings released: EPS: ₹2.33 (vs ₹2.17 in 2Q 2023) Second quarter 2024 results: EPS: ₹2.33 (up from ₹2.17 in 2Q 2023). Revenue: ₹1.04b (up 8.9% from 2Q 2023). Net income: ₹155.8m (up 15% from 2Q 2023). Profit margin: 15% (in line with 2Q 2023). Anuncio • Oct 28
Ganesh Benzoplast Limited to Report Q2, 2024 Results on Nov 07, 2023 Ganesh Benzoplast Limited announced that they will report Q2, 2024 results on Nov 07, 2023 Anuncio • Sep 06
Ganesh Benzoplast Limited, Annual General Meeting, Sep 29, 2023 Ganesh Benzoplast Limited, Annual General Meeting, Sep 29, 2023, at 11:00 Indian Standard Time. Agenda: To consider Adoption of Audited Standalone and Consolidated Financial Statements; to discuss Re-appointment of Mr. Rishi Ramesh Pilani as Director; to discuss Ratification of the remuneration of the Cost Auditors for the Financial Year 2023-24; and to Consider and Approve Raising of Funds Through Qualified Institutional Placement. Reported Earnings • Aug 12
First quarter 2024 earnings released: EPS: ₹2.37 (vs ₹1.97 in 1Q 2023) First quarter 2024 results: EPS: ₹2.37 (up from ₹1.97 in 1Q 2023). Revenue: ₹1.25b (up 36% from 1Q 2023). Net income: ₹154.9m (up 26% from 1Q 2023). Profit margin: 12% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹175, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 35% over the past year. Anuncio • Aug 04
Ganesh Benzoplast Limited to Report Q1, 2024 Results on Aug 11, 2023 Ganesh Benzoplast Limited announced that they will report Q1, 2024 results on Aug 11, 2023 Reported Earnings • May 27
Full year 2023 earnings released: EPS: ₹8.73 (vs ₹5.24 in FY 2022) Full year 2023 results: EPS: ₹8.73 (up from ₹5.24 in FY 2022). Revenue: ₹4.29b (up 20% from FY 2022). Net income: ₹550.8m (up 69% from FY 2022). Profit margin: 13% (up from 9.1% in FY 2022). The increase in margin was driven by higher revenue. Anuncio • May 19
Ganesh Benzoplast Limited to Report Q4, 2023 Results on May 25, 2023 Ganesh Benzoplast Limited announced that they will report Q4, 2023 results on May 25, 2023 Valuation Update With 7 Day Price Move • Feb 14
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹168, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 74% over the past year. Reported Earnings • Feb 08
Third quarter 2023 earnings released: EPS: ₹2.33 (vs ₹1.69 in 3Q 2022) Third quarter 2023 results: EPS: ₹2.33 (up from ₹1.69 in 3Q 2022). Revenue: ₹1.01b (down 1.0% from 3Q 2022). Net income: ₹145.1m (up 38% from 3Q 2022). Profit margin: 14% (up from 10% in 3Q 2022). The increase in margin was driven by lower expenses. Anuncio • Feb 01
Ganesh Benzoplast Limited to Report Q3, 2023 Results on Feb 07, 2023 Ganesh Benzoplast Limited announced that they will report Q3, 2023 results on Feb 07, 2023 Reported Earnings • Nov 05
Second quarter 2023 earnings released: EPS: ₹2.17 (vs ₹0.69 in 2Q 2022) Second quarter 2023 results: EPS: ₹2.17 (up from ₹0.69 in 2Q 2022). Revenue: ₹990.5m (up 21% from 2Q 2022). Net income: ₹135.1m (up 215% from 2Q 2022). Profit margin: 14% (up from 5.3% in 2Q 2022). The increase in margin was driven by higher revenue. Recent Insider Transactions • Oct 01
Chairman & MD recently bought ₹7.5m worth of stock On the 29th of September, Rishi Pilani bought around 60k shares on-market at roughly ₹126 per share. This transaction amounted to 3.8% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Rishi's only on-market trade for the last 12 months. Reported Earnings • Aug 05
First quarter 2023 earnings released: EPS: ₹1.97 (vs ₹1.50 in 1Q 2022) First quarter 2023 results: EPS: ₹1.97 (up from ₹1.50 in 1Q 2022). Revenue: ₹934.2m (up 19% from 1Q 2022). Net income: ₹123.0m (up 32% from 1Q 2022). Profit margin: 13% (up from 12% in 1Q 2022). The increase in margin was driven by higher revenue. Reported Earnings • May 30
Full year 2022 earnings released: EPS: ₹5.24 (vs ₹3.92 in FY 2021) Full year 2022 results: EPS: ₹5.24 (up from ₹3.92 in FY 2021). Revenue: ₹3.61b (up 33% from FY 2021). Net income: ₹326.9m (up 49% from FY 2021). Profit margin: 9.1% (up from 8.1% in FY 2021). The increase in margin was driven by higher revenue. Buying Opportunity • May 25
Now 20% undervalued Over the last 90 days, the stock is up 33%. The fair value is estimated to be ₹145, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 42%. Valuation Update With 7 Day Price Move • May 20
Investor sentiment improved over the past week After last week's 17% share price gain to ₹125, the stock trades at a trailing P/E ratio of 63.5x. Average trailing P/E is 18x in the Chemicals industry in India. Buying Opportunity • May 09
Now 21% undervalued Over the last 90 days, the stock is up 18%. The fair value is estimated to be ₹147, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 42%. Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment improved over the past week After last week's 20% share price gain to ₹128, the stock trades at a trailing P/E ratio of 72.4x. Average trailing P/E is 20x in the Chemicals industry in India. Reported Earnings • Feb 15
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹1.69 (down from ₹1.92 in 3Q 2021). Revenue: ₹1.03b (up 54% from 3Q 2021). Net income: ₹105.2m (down 5.7% from 3Q 2021). Profit margin: 10% (down from 17% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improved over the past week After last week's 26% share price gain to ₹98.10, the stock trades at a trailing P/E ratio of 47.9x. Average trailing P/E is 18x in the Chemicals industry in India. Reported Earnings • Nov 16
Second quarter 2022 earnings released: EPS ₹0.69 (vs ₹1.84 in 2Q 2021) The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹825.1m (up 52% from 2Q 2021). Net income: ₹43.0m (down 55% from 2Q 2021). Profit margin: 5.2% (down from 18% in 2Q 2021). The decrease in margin was driven by higher expenses. 
